ESC speaker John Cleland from the University of Hull, UK, sumed up the latest treatment available for patients with diabetes mellitus and expressed his worries about side-effects and efficacy of available anti-diabetic drugs. If you want to read his ESC abstract, just click the “read more” button.
According to a study conducted by researchers at the University of Zurich and the Zurich University Hospital the answer is: Yes. They demonstrated that one injection per month sufficed to improve blood sugar levels significantly. Even more: The insulin production of the patients improved.
Bayer HealthCare Diabetes Care unveiled the new CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.
French findings support the notion that gastric bypass can rapidly reverse diabetes symptoms' a side-effect that lap-band surgery does not show. The benefit results from a new-found element of glucose production by the intestine which also increases insulin sensitivity and lowers blood sugar.
A new analysis presented during the ESC on the effects of cardiac resynchronization therapy (CRT) in patients with mild heart failure shows improvement in several areas, including left ventricular ejection fraction, a standard measure of the heart's pumping effectiveness and key indicator of heart health.
"Surgery should be performed using as often as possible surgical mitral valve repair, as this treatment has shown safety, efficacy and good long-term results," says French Prof Alec Vahanian on Monday, the third ESC day.
The diagnostic work-up of syncope patients often raises the question of how much diagnosis is necessary and what examination methods are really needed. To save time, specialists recommend focusing on determining whether the syncope may be caused by a cardiac problem - a question answered quite easily in many cases. Karl Eberius MD, European Hospital's new correspondent, discussed advice for…
Royal Philips Electronics is to lead `euHeart´, the new European Union (EU) funded research project that aims to improve CVD diagnosis, therapy planning and treatment.
Seeking to set the agenda for urgent atrial fibrillation (AF) research, European and international cardiologists will gather this October at the European Heart House, in Sophia Antipolis, the headquarters of the European Society of Cardiology.
The ageing population and growing risk factors have made a significant impact on driving up the number of registered heart failure (HF) cases. Existing pharmacological strategies are improving the survival rates of acute and early-stage HF patients, ironically providing a growing body of patients with progression of the disease to HF.
A compressed cranial nerve by blood vessels is responsible for numerous diseases. The most well-known example is trigeminal neuralgia, which is agony for many people affected by its sudden shooting pain in the face.
This year sees the fifth anniversary of EuroPRevent.
A Canadian study published in the New England Journal of Medicine concludes that chest pain in patients with heart disease could be treated as effective with medication over time as with an expensive angioplasty.
Compact ultrasound technology provides greater diagnostic confidence within close proximity of athletes. The portable equipment from GE Healthcare is not much larger than a laptop, and delivers comparable results in terms of display quality to the high-end equipment used in hospitals.
A new paper by Shahriar Mobashery, Navari Family Professor in Life Sciences at the University of Notre Dame, and researchers in his lab provides important insights into promising new antibiotics aimed at combating MRSA.
Almost all stomach cancers not related to the heart develop from the stomach ulcer causing bug H. pylori. A Japanese study shows that treatment to eradicate the mikrobe reduces the risk of developing new gastric carcinoma in patients.
An international panel of physicians has updated the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection after evaluating recent data, according to an article in JAMA, a theme issue on HIV/AIDS.
Proton therapy is very sophisticated way of destroying tumours. Now the Swedish Medical company RaySearch Laboratories has signed a consulting agreement with Uppsala University Hospital in Sweden to develop a treatment-planning system.
Even in 2004, the medical costs for the care of stroke patients in Germany came to 7.1 billion euro. The neurologist Tobias Neumann-Haefelin of the Johann Wolfgang Goethe University in Frankfurt and his colleagues have calculated the projected number of strokes in the German federal state of Hesse for the year 2050.
The ankle brachial index, a ratio of blood pressure measurements used to indicate the risk of peripheral artery disease and atherosclerosis, may be useful to improve the accuracy of cardiovascular risk prediction, according to a meta-analysis of previous studies.
Since decades women carefully feel their breast. Hoping that they will not find any evidence for lumps or other changes, that might signal breast cancer. However, a review of recent studies conclude that self-exams do not appear to reduce deaths. Whereas radiation therapy may lower recurrence rate of rare breast cancer.
Limited public and political awareness of colorectal cancer (CRC), few formal screenings programms, delayed access to treatment - the first cross-country report on the management and funding of colorectal cancer (CRC) reveals an urgent need for action to improve the survival of patients in Europe and Australia.
When tumours are situated in difficult locations, e.g. near the brain, lungs, prostate or abdomen, patients treated with conventional radiation equipment often suffer severe side effects, which include bleeding, chronic infections or organ function limitations.
During the 2nd European Workshop on Diabetes, hosted by Bayer HealthCare Diabetes Care, experts called for uncompromising management of diabetes.
Along with MRSA and ESBL bacteria, Clostridium difficile is causing a growing problem. Epidemics of a new C. difficile strain have already occurred in hospitals in North America, England and the Benelux countries.